963 related articles for article (PubMed ID: 33776816)
1. The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children.
Libowitz MR; Nurmi EL
Front Psychiatry; 2021; 12():623681. PubMed ID: 33776816
[TBL] [Abstract][Full Text] [Related]
2. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Interventions of Atypical Antipsychotics Induced Weight Gain in the Pediatric Population: A Systemic Review of Current Evidence.
Al Jumaili W; Muzwagi A; Shah K; Trivedi C; Durga P; Mansuri Z; Jain S; Al Jumaili Y
Child Psychiatry Hum Dev; 2024 Apr; 55(2):479-487. PubMed ID: 36066654
[TBL] [Abstract][Full Text] [Related]
4. The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment.
Raben AT; Marshe VS; Chintoh A; Gorbovskaya I; Müller DJ; Hahn MK
Front Neurosci; 2017; 11():741. PubMed ID: 29403343
[No Abstract] [Full Text] [Related]
5. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
6. The effects of antipsychotic medications on microbiome and weight gain in children and adolescents.
Bretler T; Weisberg H; Koren O; Neuman H
BMC Med; 2019 Jun; 17(1):112. PubMed ID: 31215494
[TBL] [Abstract][Full Text] [Related]
7. Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial.
de Boer N; Guloksuz S; van Baal C; Willebrands L; Deenik J; Vinkers CH; Rossum IW; Zinkstok J; Wilting I; Zantvoord JB; Backx F; Swildens WE; Schouw M; Bogers J; Hulshof F; de Knijff R; Duindam P; Veereschild M; Bak M; Frederix G; de Haan L; van Os J; Cahn W; Luykx JJ
BMC Psychiatry; 2021 Jan; 21(1):4. PubMed ID: 33402159
[TBL] [Abstract][Full Text] [Related]
8. [Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management].
Ruetsch O; Viala A; Bardou H; Martin P; Vacheron MN
Encephale; 2005; 31(4 Pt 1):507-16. PubMed ID: 16389718
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans.
Maciukiewicz M; Tiwari AK; Zai CC; Gorbovskaya I; Laughlin CP; Nurmi EL; Liebermann JA; Meltzer HY; Kennedy JL; Müller DJ
Schizophr Res; 2019 Oct; 212():204-212. PubMed ID: 31447353
[TBL] [Abstract][Full Text] [Related]
10. [Prevention and treatment of antipsychotic induced weight gain].
Veerman SRT; Cohen D
Tijdschr Psychiatr; 2023; 65(4):259-265. PubMed ID: 37323046
[TBL] [Abstract][Full Text] [Related]
11. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
Maher AR; Theodore G
J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311
[TBL] [Abstract][Full Text] [Related]
12. Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain.
Maciukiewicz M; Gorbovskaya I; Tiwari AK; Zai CC; Freeman N; Meltzer HY; Kennedy JL; Müller DJ
J Neural Transm (Vienna); 2019 Jan; 126(1):27-33. PubMed ID: 30229349
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory Cytokines and Antipsychotic-Induced Weight Gain: Review and Clinical Implications.
Fonseka TM; Müller DJ; Kennedy SH
Mol Neuropsychiatry; 2016 May; 2(1):1-14. PubMed ID: 27606316
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic-Induced Weight Gain in Severe Mental Illness: Risk Factors and Special Considerations.
Stogios N; Humber B; Agarwal SM; Hahn M
Curr Psychiatry Rep; 2023 Nov; 25(11):707-721. PubMed ID: 37755655
[TBL] [Abstract][Full Text] [Related]
15. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
16. Herbal Therapies for Weight Gain and Metabolic Abnormalities Induced by Atypical Antipsychotics: A Review Article.
Naghibi H; Salari R; Yousefi M; Khadem-Rezaiyan M; Ghanbarzadeh MR; Fayyazi Bordbar MR
Curr Drug Discov Technol; 2023; 20(5):e110423215660. PubMed ID: 37055899
[TBL] [Abstract][Full Text] [Related]
17. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.
Maayan L; Correll CU
J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):517-35. PubMed ID: 22166172
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic factors associated with amisulpride-induced weight gain in first-episode psychosis patients (from the OPTiMiSE cohort).
Pandit R; Cianci D; Ter Hark SE; Winter-van Rossum I; Ebdrup BH; Broberg BV; Garcia-Portilla MP; Bobes J; Vinkers CH; Kahn RS; Guloksuz S; Huitema ADR; Luykx JJ
Acta Psychiatr Scand; 2019 Sep; 140(3):283-290. PubMed ID: 31323113
[TBL] [Abstract][Full Text] [Related]
19. A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia.
Gonçalves VF; Zai CC; Tiwari AK; Brandl EJ; Derkach A; Meltzer HY; Lieberman JA; Müller DJ; Sun L; Kennedy JL
Neuropsychopharmacology; 2014 May; 39(6):1347-54. PubMed ID: 24196945
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
